Literature DB >> 35535570

Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?

Ahmad Mourad1, Thomas L Holland1,2, Nicholas A Turner1.   

Abstract

In this invited commentary, we reflect on the accompanying study by A. R. Caffrey, H. J. Appaneal, K. L. LaPlante, V. V. Lopes, et al. (Antimicrob Agents Chemother 66:e02117-21, 2022, https://doi.org/10.1128/aac.02117-21), which analyzed the impact of clopidogrel use on clinical outcomes in Staphylococcus aureus bacteremia.

Entities:  

Keywords:  Staphylococcus aureus; bacteremia; clopidogrel

Mesh：

Substances：

Year:  2022        PMID： 35535570      PMCID： PMC9211407          DOI： 10.1128/aac.00365-22

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


  16 in total

1.  Modifiers of symptomatic embolic risk in infective endocarditis.

Authors:  Nandan S Anavekar; Jason C Schultz; Daniel D Correa De Sa; Justin M Thomas; Brian D Lahr; Imad M Tleyjeh; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.

Authors:  Aisling R Caffrey; Haley J Appaneal; Kerry L LaPlante; Vrishali V Lopes; Erlinda R Ulloa; Victor Nizet; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

3.  Clinical Outcomes Associated With the Use of Anticoagulant and Antiplatelet Agents in Patients Undergoing Treatment for Infective Endocarditis: A Pilot Study.

Authors:  Sherin M Pathickal; Tae Eun Park; Roopali Sharma
Journal:  Clin Ther       Date:  2020-08-02       Impact factor: 3.393

4.  Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Authors:  Tiago Rafael Veloso; Yok-Ai Que; Aziz Chaouch; Marlyse Giddey; Jacques Vouillamoz; Valentin Rousson; Philippe Moreillon; José Manuel Entenza
Journal:  J Infect Dis       Date:  2014-08-01       Impact factor: 5.226

5.  A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.

Authors:  Kwan-Leung Chan; Jean G Dumesnil; Bibiana Cujec; Anthony J Sanfilippo; John Jue; Michele A Turek; Trevor I Robinson; David Moher
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

6.  Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia.

Authors:  Erlinda R Ulloa; Satoshi Uchiyama; Robert Gillespie; Victor Nizet; George Sakoulas
Journal:  J Infect Dis       Date:  2021-11-16       Impact factor: 5.226

7.  Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study.

Authors:  Robert F Storey; Stefan K James; Agneta Siegbahn; Christoph Varenhorst; Claes Held; Joseph Ycas; Steen E Husted; Christopher P Cannon; Richard C Becker; Ph Gabriel Steg; Nils Åsenblad; Lars Wallentin
Journal:  Platelets       Date:  2013-10-15       Impact factor: 3.862

8.  Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Authors:  Athena P Kourtis; Kelly Hatfield; James Baggs; Yi Mu; Isaac See; Erin Epson; Joelle Nadle; Marion A Kainer; Ghinwa Dumyati; Susan Petit; Susan M Ray; David Ham; Catherine Capers; Heather Ewing; Nicole Coffin; L Clifford McDonald; John Jernigan; Denise Cardo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-08       Impact factor: 17.586

9.  Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials.

Authors:  Eliano P Navarese; Safi U Khan; Michalina Kołodziejczak; Jacek Kubica; Sergio Buccheri; Christopher P Cannon; Paul A Gurbel; Stefano De Servi; Andrzej Budaj; Antonio Bartorelli; Daniela Trabattoni; E Magnus Ohman; Lars Wallentin; Matthew T Roe; Stefan James
Journal:  Circulation       Date:  2020-05-29       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.